Aquestive Therapeutics Inc. (NASDAQ: AQST) reported Q1 EPS of ($0.07), $0.06 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $14.4 million versus the consensus estimate of $10.9 million.

For earnings history and earnings-related data on Aquestive Therapeutics Inc. (AQST) click here.